Nath Bio-Genes (India) Limited (NATHBIOGEN) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.160x

Based on the latest financial reports, Nath Bio-Genes (India) Limited (NATHBIOGEN) has a cash flow conversion efficiency ratio of -0.160x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-1.09 Billion ≈ $-11.75 Million USD) by net assets (Rs6.80 Billion ≈ $73.52 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Nath Bio-Genes (India) Limited for the company's overall valuation and market capitalisation.

Nath Bio-Genes (India) Limited - Cash Flow Conversion Efficiency Trend (2013–2026)

This chart illustrates how Nath Bio-Genes (India) Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Nath Bio-Genes (India) Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nath Bio-Genes (India) Limited ranked by their cash flow conversion efficiency. Explore Nath Bio-Genes (India) Limited (NATHBIOGEN) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
DOREL INDS INC. B
F:DO4B
-0.047x
K-One Technology Bhd
KLSE:0111
-0.022x
Vulcan Infrastructure and Power Inc.
NASDAQ:VIP
0.076x
Klondike Gold Corp
V:KG
-0.008x
Wave Electronics Co. Ltd
KQ:095270
-0.010x
Laurion Mineral Exploration Inc
V:LME
-0.278x
Exxaro Tiles Limited
NSE:EXXARO
0.054x
Sapmer
PA:ALMER
0.004x

Annual Cash Flow Conversion Efficiency for Nath Bio-Genes (India) Limited (2013–2026)

The table below shows the annual cash flow conversion efficiency of Nath Bio-Genes (India) Limited from 2013 to 2026. View today's stock price for Nath Bio-Genes (India) Limited for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs6.80 Billion
≈ $73.59 Million
Rs-220.35 Million
≈ $-2.38 Million
-0.032x -218.69%
2025-03-31 Rs6.44 Billion
≈ $69.69 Million
Rs175.81 Million
≈ $1.90 Million
0.027x -72.93%
2024-03-31 Rs6.10 Billion
≈ $65.96 Million
Rs614.80 Million
≈ $6.65 Million
0.101x +50.59%
2023-03-31 Rs5.73 Billion
≈ $61.99 Million
Rs383.67 Million
≈ $4.15 Million
0.067x +112.82%
2022-03-31 Rs5.42 Billion
≈ $58.61 Million
Rs170.46 Million
≈ $1.84 Million
0.031x +1633.30%
2021-03-31 Rs6.13 Billion
≈ $66.32 Million
Rs11.13 Million
≈ $120.35K
0.002x -89.32%
2020-03-31 Rs5.58 Billion
≈ $60.30 Million
Rs94.74 Million
≈ $1.02 Million
0.017x +139.22%
2019-03-31 Rs5.08 Billion
≈ $54.89 Million
Rs-219.89 Million
≈ $-2.38 Million
-0.043x +56.74%
2018-03-31 Rs4.69 Billion
≈ $50.75 Million
Rs-469.84 Million
≈ $-5.08 Million
-0.100x -512.04%
2017-03-31 Rs1.38 Billion
≈ $14.88 Million
Rs33.43 Million
≈ $361.58K
0.024x +120.81%
2016-03-31 Rs1.21 Billion
≈ $13.12 Million
Rs-141.68 Million
≈ $-1.53 Million
-0.117x -285.23%
2015-03-31 Rs1.07 Billion
≈ $11.59 Million
Rs67.55 Million
≈ $730.58K
0.063x -65.69%
2014-03-31 Rs817.78 Million
≈ $8.84 Million
Rs150.28 Million
≈ $1.63 Million
0.184x -25.68%
2013-03-31 Rs574.74 Million
≈ $6.22 Million
Rs142.11 Million
≈ $1.54 Million
0.247x --

About Nath Bio-Genes (India) Limited

NSE:NATHBIOGEN India Agricultural Inputs
Market Cap
$30.28 Million
Rs2.80 Billion INR
Market Cap Rank
#23846 Global
#1312 in India
Share Price
Rs147.34
Change (1 day)
-0.54%
52-Week Range
Rs129.02 - Rs196.01
All Time High
Rs537.81
About

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; plant nutrient supplements; pearl millets; seeds for field crops, such as bajra, maize, corn, paddy, wheat, and jow… Read more